The purpose of the Healthcare Technology Assessment SIG is to provide statisticians working in the Pharmaceutical Industry engaged in Health Technology Assessments, and others in related fields of research, an opportunity to:
| Name | Company/Institution |
| Abdallah Abouihia | Medtronic |
| Robert Bauer | Novo Nordisk |
| Thomas Bartmus | MSD |
| Mark Belger | Eli Lilly |
| Sarah Böhme | Pfizer |
| Simone Borley | MAP BioPharma |
| Ian Bridges | Amgen |
| Monika Bruederl | AMS |
| Ash Bullement | Deltahat |
| Chrissie Fletcher | GSK |
| Lili Fokas | Numerus |
| Christoph Gerlinger | Bayer |
| Ralph Goertz | AMS |
| Monika Groebner | MSD |
| Necdat Gunsoy | AbbVie |
| Jes Birger Hansen | Leo |
| Michael Hennig | GSK |
| Kirsten Hermann | Genomic Health |
| Cristina Ivanescu | Quintiles |
| Rita Kristy | Astellas |
| Katrin Kupas | BMS |
| Friedhelm Leverkus | Pfizer |
| Yannis Jemiai | Cytel |
| Jan McKendrick | PRMA Consulting |
| Shahrul Mt-Isa | MSD |
| Claudia Nicolay | Eli Lilly |
| Marie-Ange Paget | Eli Lilly |
| Carol Reid | Roche |
| Kate Ren | University of Sheffield |
| Barbara Rosettani | Celgene |
| Owain Saunders | AZ |
| Michael Schlichting | Merck KgaA |
| Fred Sorenson | Xcenda |
| Achim Steup | Astellas |
| Alexandra Thiele | AMS |
| Stefanie Tuebben | MSD |
| Karan Vadher | Eli Lilly |
| Jason Wang | Celgene |
| William Wang | MSD |
| Claire Watkins | ClaroStat Consulting |
| Stefan Wiefarn | MSD |
| Lara Wolfson | MSD |
| Caroline Whately-Smith | Consultant |
If you have any questions relating to HTA, need further information or wish to join the HTA ESIG please contact Chrissie Fletcher or Lara Wolfson (co-chairs).
For an introduction to HTA please read the HTA handbook which you can access on the PSI website under Resources (go to the HTA SIG/HTA handbook folder). The handbook contains useful links to a variety of HTA related resources including HTA agency websites, HTA guidelines, recommended books and reference materials. Key statistical challenges relating to HTA are also discussed.
For 1-day HTA scientific meetings please view past Scientific meetings on the PSI Website and the Basel Biometrics Section (BBS) website.
For HTA related conference sessions, please view past PSI Conferences on the PSI Website and the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) website.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
This presentation will give some background regarding the ‘Carcinogenicity Statistics Discussion Group’. The talk will review the history of the group, outline the current status, and give an overview of the types of topics discussed.
This year's Annual General Meeting will focus on how PSI has navigated the challenges of the past year and adapted to the new online world, as well as how we plan to embrace a new Board structure and new opportunities as we move forward.
Our next journal club features two papers on the topic of “The Use of External Controls in Clinical Trials”. Please join us to hear Chris Harbron (Roche) and Margaret Gamalo (Pfizer) present their recent work. The webinar will be chaired by Nigel Stallard (Warwick University).
We’re now searching at all levels for Biostatisticians and Statistical Programmers to join our International BARDS Health Technology Assessment team at our London and Zurich hubs.
The Associate Director of Biostatistics is the key client interface for all statistical issues and discussions.
In this role you will consult in the design of complex and innovative studies and clinical trial programs as well as Leading DMC/DSMB processes.
Join our growing team and discover your extraordinary potential by working as a Covance by Labcorp Biostatistician 2 within our early phase biostatistics department.
This is an excellent opportunity for someone that loves working directly with clients, contributing as a high-level project lead and key contributor.
Join our growing team and discover your extraordinary potential by working as a Covance by Labcorp Principal Biostatistician.
As a seasoned Biostatistician, will work primarily on Immunology: GI and Dermatology trials with a focus on Late Phase studies. Some PK Analysis experience highly desired.
As a seasoned Biostatistician, will work primarily in late phase oncology.
As an experienced pharmaceutical statistician, you will support Cytel and a client of our Functional Service Provider (FSP) division.
As a Sr Bios, you will function independently as Lead Statistician on projects and support/project statistician on others.
As a Sr Mgr, Biostatistics you will manage a team of Statisticians and Programmers within the FSP department, as well as managing project work.
At its core, the role of a Senior Statistician at Veramed is to provide statistical support to the statistics and programming department across a range of projects, clients and therapeutic areas.
As a Senior or Principal Biotatistician, you will hold a combined project leadership and hands-on technical statistics role, working across a range of phases and therapeutic areas.
You will participate in the development of study protocols including participation in study design discussions and sample size calculations, and review CRFs and data review guidelines.
As a Senior or Principal Statistician, you will hold a combined project leadership and hands-on technical statistics role., working across a range of phases and therapeutic areas.
We are looking for passionate and motivated statisticians to work within our Services team to deliver high quality, innovative, analytical services within a clinical setting as our KerusCloud platform moves into the next phase.
Would you like to join a dynamic, growing firm where you can really make an impact, not just on the company but to accelerate drug development and ultimately benefit patients?
Have you experience in the application of statistics in the pharmaceutical, healthcare or life science sectors? Do you want to be at the forefront of statistical innovations, leading the way on clinical trial design and analysis?
As a Statistics Manager, you will hold a combined line management, project leadership and technical statistical role, working across a range of phases and therapeutic areas.
